News & Views

  • Grant Support for UK Viral Vector Manufacturing

Grant Support for UK Viral Vector Manufacturing

Feb 28 2018 Read 622 Times

Contract development and manufacturing organisation Cobra Biologics and Symbiosis Pharmaceutical Services, a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, have been awarded a 16-month collaborative grant of £1.9m from Innovate UK.

Helping to establishing the commercial viral vector manufacturing capabilities within the UK, the joint investment project, costing £4.8m in total, aims to develop world leading capabilities for clinical and commercial production of gene and immunotherapy viral vectors for both drug substance and drug product manufacturing .

Peter Coleman, Chief Executive at Cobra Biologics said: “Cell and gene therapy products are showing tremendous potential in the treatment of patients. The successful development and production of viral vectors to deliver these therapies is critical to the success of these products. I am looking forward to working closely with Symbiosis to help establish the UK as world leader in is this exciting field.”

Colin MacKay, Chief Executive of Symbiosis added: “We are delighted to be working with Cobra on this project with the aim of developing a UK-based supply chain to both facilitate and accelerate the successful clinical and commercial manufacture of viral vectors.”

Dr Ian Campbell, Director of Health and Life Sciences, Innovate UK, said: “The UK is at the forefront of research into these new therapies, but there is a global shortage in viral vector manufacturing capacity and we need to act to take advantage of the commercial opportunities. Innovate UK funding for this vital project can help boost this sector and meet the needs of patients in the future.”

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Lab Asia February 2019

February 2019

In this edition Articles - Detection of molecular markers in aquatic sediments by ion profi les obtained by GC/MS system - Fighting the Resistance: How Rapid Microbial ID with MALDI MS and A...

View all digital editions

Events

BioPharma World Expo 2019

Feb 20 2019 Mumbai, India

Medical Fair India 2019

Feb 21 2019 New Delhi, India

Biotech World

Feb 25 2019 Moscow, Russia

China Lab 2019

Feb 26 2019 Guangzhou, China

SmartLab Exchange

Feb 27 2019 Berlin, Germany

View all events